Consensus statement on physician training for the treatment of dystonia with botulinum toxin. The Canadian Movement Disorders Group.
D001905:Botulinum Toxins / Q000627:therapeutic use*; D002170:Canada; D002983:Clinical Competence; D004421:Dystonia / Q000188:drug therapy*; D004501:Education, Medical / Q000592:standards*; D006801:Humans
D001905:Botulinum Toxins